Sector updates in November
Investment firms
- Sofinnova Partners successfully closes its latest flagship fund, Sofinnova Capital XI, with €650 million to back a new generation of pioneering biopharmaceutical and medical technology companies addressing urgent unmet clinical needs
- Medicxi successfully closes its sixth fund, Medicxi V, with €500 million dedicated to building and backing innovative biotechnology companies with clear product visions to transform patient care.
- Forbion successfully closes its €200 million BioEconomy Fund I to target investments at the nexus of biotechnology and planetary health
- United Founders, a new pre-seed and seed stage fund, launches with a successful close of €30 million. The fund will back deeptech and emerging tech startups
- Philip Brainin left his role as Associate at Sound Bioventures
- Khatereh Ahmadi appointed Venture Partner at XGEN Venture
Analysts/Banking/ Associations
- Arnaldo De Lisio appointed Managing Partner at Catalyst Advisors
- Daniel Parisotto appointed Co-Head of Healthcare Investment Banking at Societe Generale
Media
- Aanu Adeoye appointed acting Global Pharmaceuticals Correspondent, covering Hannah Kuchler’s maternity leave at the Financial Times
- Kai Nicol-Schwarz, previously Senior Reporter at Sifted, appointed Reporter and CNBC
- Nathan Ni left his role as Senior Science Editor at The Scientist
- Rob Coker left his role as Deputy Editor at Medicine Maker
- Rebecca Forand left her role as Executive Editor at Healio
- Shawn Zeller appointed Healthcare Editor at POLITICO (US)
- Erin Schumaker appointed Health Care Editor at POLITICO (US)
- Madeleine Varner appointed Senior Writer at WIRED US
- Susanna Galton promoted to Senior Health Features Writer at The Daily Telegraph
- Charlotte Moore left her role as Head of Health, Features at The Daily Telegraph and appointed Editor of Femail at the Daily Mail
- Wiliam Hunter appointed Senior Technology & Science Reporter at The Daily Mail online

